Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

  • August 21, 2018
Table of Contents

Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

A team of researchers headed by University of British Columbia scientist Stephen Withers reports on enzymes — from the human gut — that remove A or B antigens from red blood cells 30 times more efficiently than previously reported enzymes. To assess potential enzyme candidates more quickly, Dr. Withers and colleagues used a technique called metagenomics. The team considered sampling DNA from mosquitoes and leeches, the types of organisms that degrade blood, but ultimately found successful candidate enzymes in the human gut microbiome.

Glycosylated proteins called mucins line the gut wall, providing sugars that serve as attachment points for gut bacteria while also feeding them as they assist in digestion. Some of the mucin sugars are similar in structure to the antigens on A- and B-type blood. The scientists homed in on the enzymes the bacteria use to pluck the sugars off mucin and found a new family of enzymes that are 30 times more effective at removing red blood cell antigens than previously reported candidates.

The researchers presented their results today at the 256th National Meeting & Exposition of the American Chemical Society in Boston, Massachusetts.

Source: sci-news.com

Share :
comments powered by Disqus

Related Posts

Drone Delivery Becomes a Reality in Remote Pacific Islands

Drone Delivery Becomes a Reality in Remote Pacific Islands

Currently, health workers in Vanuatu often hike over mountains to deliver vaccines–but drones can fly over them. This September, delivery drones will begin to fly the friendly skies of Vanuatu. And this isn’t a one-shot demonstration, like many of the stunts we’ve seen from the likes of Amazon and Google.

Read More
New anti-cancer drugs put cancers to sleep—permanently

New anti-cancer drugs put cancers to sleep—permanently

In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies. Published today in the journal Nature, the research reveals the first class of anti-cancer drugs that work by putting the cancer cell to sleep – arresting tumour growth and spread without damaging the cells’ DNA. The new class of drugs could provide an exciting alternative for people with cancer, and has already shown great promise in halting cancer progression in models of blood and liver cancers, as well as in delaying cancer relapse.

Read More